In-situ forming gel

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Injectable

Duration Type: Long-acting

Description: In-situ forming gel comprised of low molecular weight poly (ε-caprolactone) (PCL) and biocompatible solvents. The solvent in the polymer solution dissipates post-injection, leaving behind a biodegradable gel depot that slowly releases levonorgestrel.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: 2016

Status Details:
  • Feasibility studies of injectable in situ gel systems with low initial burst release followed by constant release profiles, in vitro.

Download Product Report